174 related articles for article (PubMed ID: 32608276)
21. The Basic Requirement of Tight Junction Proteins in Blood-Brain Barrier Function and Their Role in Pathologies.
Dithmer S; Blasig IE; Fraser PA; Qin Z; Haseloff RF
Int J Mol Sci; 2024 May; 25(11):. PubMed ID: 38891789
[TBL] [Abstract][Full Text] [Related]
22. 17β-Estradiol Ameliorates Tight Junction Disruption via Repression of MMP Transcription.
Na W; Lee JY; Kim WS; Yune TY; Ju BG
Mol Endocrinol; 2015 Sep; 29(9):1347-61. PubMed ID: 26168035
[TBL] [Abstract][Full Text] [Related]
23. Moderate hypoxia followed by reoxygenation results in blood-brain barrier breakdown via oxidative stress-dependent tight-junction protein disruption.
Zehendner CM; Librizzi L; Hedrich J; Bauer NM; Angamo EA; de Curtis M; Luhmann HJ
PLoS One; 2013; 8(12):e82823. PubMed ID: 24324834
[TBL] [Abstract][Full Text] [Related]
24. Involvement of ROS in BBB dysfunction.
Pun PB; Lu J; Moochhala S
Free Radic Res; 2009 Apr; 43(4):348-64. PubMed ID: 19241241
[TBL] [Abstract][Full Text] [Related]
25. Oxidative stress activates protein tyrosine kinase and matrix metalloproteinases leading to blood-brain barrier dysfunction.
Haorah J; Ramirez SH; Schall K; Smith D; Pandya R; Persidsky Y
J Neurochem; 2007 Apr; 101(2):566-76. PubMed ID: 17250680
[TBL] [Abstract][Full Text] [Related]
26. Caveolin1 Is Required for Th1 Cell Infiltration, but Not Tight Junction Remodeling, at the Blood-Brain Barrier in Autoimmune Neuroinflammation.
Lutz SE; Smith JR; Kim DH; Olson CVL; Ellefsen K; Bates JM; Gandhi SP; Agalliu D
Cell Rep; 2017 Nov; 21(8):2104-2117. PubMed ID: 29166603
[TBL] [Abstract][Full Text] [Related]
27. Progranulin deficiency promotes post-ischemic blood-brain barrier disruption.
Jackman K; Kahles T; Lane D; Garcia-Bonilla L; Abe T; Capone C; Hochrainer K; Voss H; Zhou P; Ding A; Anrather J; Iadecola C
J Neurosci; 2013 Dec; 33(50):19579-89. PubMed ID: 24336722
[TBL] [Abstract][Full Text] [Related]
28. Connexin 43 gap junctions contribute to brain endothelial barrier hyperpermeability in familial cerebral cavernous malformations type III by modulating tight junction structure.
Johnson AM; Roach JP; Hu A; Stamatovic SM; Zochowski MR; Keep RF; Andjelkovic AV
FASEB J; 2018 May; 32(5):2615-2629. PubMed ID: 29295866
[TBL] [Abstract][Full Text] [Related]
29. Dual Roles of Astrocyte-Derived Factors in Regulation of Blood-Brain Barrier Function after Brain Damage.
Michinaga S; Koyama Y
Int J Mol Sci; 2019 Jan; 20(3):. PubMed ID: 30699952
[TBL] [Abstract][Full Text] [Related]
30. Tight junction modulators for drug delivery to the central nervous system.
Hashimoto Y; Tachibana K; Kondoh M
Drug Discov Today; 2020 Aug; 25(8):1477-1486. PubMed ID: 32439607
[TBL] [Abstract][Full Text] [Related]
31. Methamphetamine alters blood brain barrier permeability via the modulation of tight junction expression: Implication for HIV-1 neuropathogenesis in the context of drug abuse.
Mahajan SD; Aalinkeel R; Sykes DE; Reynolds JL; Bindukumar B; Adal A; Qi M; Toh J; Xu G; Prasad PN; Schwartz SA
Brain Res; 2008 Apr; 1203():133-48. PubMed ID: 18329007
[TBL] [Abstract][Full Text] [Related]
32. Specific role of tight junction proteins claudin-5, occludin, and ZO-1 of the blood-brain barrier in a focal cerebral ischemic insult.
Jiao H; Wang Z; Liu Y; Wang P; Xue Y
J Mol Neurosci; 2011 Jun; 44(2):130-9. PubMed ID: 21318404
[TBL] [Abstract][Full Text] [Related]
33. Matrix metalloproteinase-9 mediates hypoxia-induced vascular leakage in the brain via tight junction rearrangement.
Bauer AT; Bürgers HF; Rabie T; Marti HH
J Cereb Blood Flow Metab; 2010 Apr; 30(4):837-48. PubMed ID: 19997118
[TBL] [Abstract][Full Text] [Related]
34. IFN-γ, IL-17A, or zonulin rapidly increase the permeability of the blood-brain and small intestinal epithelial barriers: Relevance for neuro-inflammatory diseases.
Rahman MT; Ghosh C; Hossain M; Linfield D; Rezaee F; Janigro D; Marchi N; van Boxel-Dezaire AHH
Biochem Biophys Res Commun; 2018 Dec; 507(1-4):274-279. PubMed ID: 30449598
[TBL] [Abstract][Full Text] [Related]
35. Blood-brain barrier tight junction permeability and ischemic stroke.
Sandoval KE; Witt KA
Neurobiol Dis; 2008 Nov; 32(2):200-19. PubMed ID: 18790057
[TBL] [Abstract][Full Text] [Related]
36. The blood-brain barrier/neurovascular unit in health and disease.
Hawkins BT; Davis TP
Pharmacol Rev; 2005 Jun; 57(2):173-85. PubMed ID: 15914466
[TBL] [Abstract][Full Text] [Related]
37. miR-27a-3p regulates expression of intercellular junctions at the brain endothelium and controls the endothelial barrier permeability.
Harati R; Hammad S; Tlili A; Mahfood M; Mabondzo A; Hamoudi R
PLoS One; 2022; 17(1):e0262152. PubMed ID: 35025943
[TBL] [Abstract][Full Text] [Related]
38. Role of Matrix Metalloproteinases in the Pathogenesis of Traumatic Brain Injury.
Abdul-Muneer PM; Pfister BJ; Haorah J; Chandra N
Mol Neurobiol; 2016 Nov; 53(9):6106-6123. PubMed ID: 26541883
[TBL] [Abstract][Full Text] [Related]
39. Chronic inflammatory pain leads to increased blood-brain barrier permeability and tight junction protein alterations.
Brooks TA; Hawkins BT; Huber JD; Egleton RD; Davis TP
Am J Physiol Heart Circ Physiol; 2005 Aug; 289(2):H738-43. PubMed ID: 15792985
[TBL] [Abstract][Full Text] [Related]
40. Aβ₁₋₄₂-RAGE interaction disrupts tight junctions of the blood-brain barrier via Ca²⁺-calcineurin signaling.
Kook SY; Hong HS; Moon M; Ha CM; Chang S; Mook-Jung I
J Neurosci; 2012 Jun; 32(26):8845-54. PubMed ID: 22745485
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
